Financials
- Market Capitalization 405.51 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3030 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.80 USD | +2.15% | +0.80% | +21.41% | +16.21% | 417.14 M USD | ||
| 3031 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.31 USD | -3.35% | -8.70% | +19.07% | -33.04% | 416.00 M USD | ||
| 3051 | LRMR Larimar Therapeutics, Inc. - Common Stock | 3.89 USD | +1.83% | -6.27% | +1.57% | +6.28% | 404.10 M USD | ||
| 3085 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.40 USD | +0.53% | -6.62% | +5.51% | +54.02% | 390.28 M USD |